GWG Consulting offers expert advice on the planning, development and execution of regional and national market access strategies. This advice straddles the entire clinical development pathway from horizon scanning for new medicines in clinical development through health technology appraisal to access to new medicines by patients in the UK. We are experts in evidence-based analysis and critical appraisal of corporate strategy, research and development strategy, company and comparator company research and development pipelines, individual product and therapy area profiles.
Our Medical Writing Services
We offer exceptional editorial capabilities with the ability to present complex data and information in a format that suits your needs. This may include in-depth, high quality reports and documentation, guidelines, policies and procedures, for dissemination at all levels to help direct strategy across your organisations. We also have extensive experience of writing clinical manuscripts, developing training material and disease and therapy specific reports such as disease area strategy reviews and horizon scanning drug monographs and national reports. In addition to our exceptional writing capabilities we offer in-depth peer review and analysis, proof reading and editing services.
In addition, we offer support and guidance on the use of the national horizon scanning database, UK PharmaScan. Following regulatory review, we offer support and guidance on pharmaceutical company submissions to the Health Technology Assessment (HTA) organisations in the UK: the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG). This includes the provision of strategic advice and guidance on a company’s approach to a submission, review and analysis of all aspects of the submission, drafting sections of the submission and reviewing completed submissions.
GWG Consulting can organise and lead advisory boards on all aspects of market access for new medicines or can provide expert input to advisory boards as required. Through our tailored solutions we can also support company activities at NHS Board level regarding aspects such as formulary management and education on new medicines, as well as providing advice on access to new medicines that are not recommended for use by the HTA organisations.
Our medical writing services are underpinned by expertise in evidence-based analysis that utilises sector knowledge, commercial awareness, literature reviewing skills and a broad range of analytical techniques and methodologies.